Treatment of common warts with topical solution of potassium hydroxide 15%

Comparison of efficacy and side effects of topical 15% potassium hydroxide solution and cryotherapy in the treatment of common wart.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014081118765N1

Enrollment

Registered

2014-12-12

Start date

2012-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common wart. Verruca Vulgaris

Interventions

Intervention 1: Intervention group: Drug: Topical solution of 15% Potassium hydroxide Direct education to patients. Period of application: Disappearance of warts Application: Cotton swap weltering i

Treatment - Drugs

Intervention group: Drug: Topical solution of 15% Potassium hydroxide Direct education to patients. Period of application: Disappearance of warts Application: Cotton swap weltering in solution of

Control group :Treatment with cryotherapy Application: One cotton swap be drowned in to nitrogen liquid then put on each wart for ten seconds and repeat it twice.

Eligibility

Sex/Gender

All

Age

3 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient who have common wart with diameter less than 5 mm, on the hand or foot bilaterally. Exclusion criteria: pregnancy; lactation; treatment during one recent month; secondary skin infection

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reduced size of Common warts. Timepoint: Before intervention. Every week from starting of intervention to disappearance of all warts. Two months after the end of intervention. Method of measurement: observation; Ruler.	—

Secondary

Measure	Time frame
Side effects. Timepoint: Before intervention. Every week from starting of intervention to disappearance of all warts. Two months after the end of intervention. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSalah Shohani

Ahvaz Jundishapur University of Medical Sciences

shohani.s@ajums.acir+98 61 1222 2114

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026